NEW YORK, Jan. 15 (GenomeWeb News) - Structural Genomix said today it will provide Eli Lilly with long-term access to the SGX synchrotron beamline facility at the Advanced Photon Source at Argonne National Laboratory in Chicago.
SGX, of San Diego, Calif., will generate x-ray crystallography data on drug targets and compounds provided by Lilly. In return, Lilly will pay SGX an upfront access fee and an annual fee to cover operating costs. Lilly also has the option to expand its access to the beamline in the future for additional payments.
SGX has been providing Lilly with its high-throughput protein crystallography technology since last April.